ArticleArchives of microbiology2025
Effect of TRIM67 knockout on inflammation and macrophage survival in Salmonella Typhimurium-infected mice.
Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Salmonella enterica serovar Typhimurium (S. Typhimurium) is a pathogenic bacterium that causes acute gastroenteritis. Macrophages play a crucial role in modulating inflammatory responses and eliminating S. Typhimurium infections. In this study, we identified TRIM67, a tripartite motif protein, as a key mediator of macrophage immunity against S. Typhimurium infection. Using S. Typhimurium mouse models, we evaluated the impact of TRIM67 deficiency on liver and spleen inflammation under both normal physiological conditions and S. Typhimurium infection. Mechanistic insights into TRIM67-mediated inflammatory effects were investigated through immunohistochemistry and Western blotting. For in vitro experiments, primary peritoneal macrophages were isolated from Wild-Type(WT) and TRIM67-knockout(KO) mice, and generated TRIM67-overexpressing RAW 264.7 macrophage cell lines. We assessed bacterial load, survival rates, and macrophage-mediated immune responses following S. Typhimurium infection. Our results demonstrated that KO mice exhibited heightened susceptibility to S. Typhimurium infection compared to WT mice. TRIM67 knockout suppressed inflammation in the liver and spleen, impaired monocyte recruitment to infection sites, and reduced macrophage numbers, ultimately leading to increased mortality. Furthermore, TRIM67 knockout inhibited the activation of mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB) signaling pathways, thereby attenuating macrophage immunity and the production of pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6. This study unveils a novel role for TRIM67 in protecting mice against S. Typhimurium infection by regulating inflammation and macrophage survival.
Indexed as
Identifiers
40824551What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.